The Division of Dermatology is active in research and actively participating in national and international clinical trials. We welcome undergraduate and postgraduate students who have interest in pursuing research projects related to our field. Our researchers have presented award-winning papers at national and international conferences, produced publications in various dermatological journals and are reviewers for many peer reviewed journals.
Qualified individuals who would like to be involved in various research opportunities at the Division of Dermatology are welcome to apply for suitable positions by contacting us via email at umdermatology@gmail.com. We also welcome undergraduate medical students who would like to pursue elective postings in Dermatology at our hospital. Applications can be made through the UMMC website.
|
1
|
Vitamin D receptor gene polymorphisms and serum vitamin D level in hypopigmented mycosis fungoides: A case-control study in Malaysian patients
|
|
2
|
Clinical course and histopathology findings in cutaneous graft-versus-host disease (GVHD): A case series of adult patients undergoing hematopoeitic stem cell transplantation
|
|
3
|
Association of skin microbial dysbiosis and host genetics with fungal skin infections among underserved communities |
|
4
|
Quality of life, psychological burden, and treatment satisfaction of patients with chronic urticaria in Klang Valley, Malaysia
|
|
5
|
Cutaneous acute graft versus host disease (aGVHD) and related dermoscopic changes in patients with skin of colour.
|
|
6
|
Retrospective review of histopathological features of cutaneous manifestations of HIV patients in University of Malaya Medical Centre 2016-2018
|
|
7
|
HLA-B*58:01 allele testing in primary care to prevent allopurinol-induced severe cutaneous adverse reaction
|
|
9
|
Retrospective review of skin cancers in UMMC from year 2015 to 2018
|
|
10
|
Development and characterization of human fibroblast-derived matrices-based human skin equivalent as a novel in-vitro psoriatic model for drug testing
|
|
1
|
A Phase 3b Multicenter, Randomized, Double-Blind, Double-Dummy, Active Controlled Study Comparing the Safety and Efficacy of Upadacitinib to Dupilumab in Adult Subjects with Moderate to Severe Atopic Dermatitis
|
|
2
|
A Phase 3, Randomized, Double-Blind, Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy (KEEPsAKE 1)
|
|
3
|
A Phase 3b, open-label treatment extension study of upadacitinib for the treatment of adult subjects with moderate to severe atopic dermatitis who completed treatment in study M16-046
|
|
4
|
A Phase 3, Randomized, 24-week, Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety, and Tolerability of Rocatinlimab (AMG 451) in Combination with Topical Corticosteroids and/or Topical Calcineurin Inhibitors in Adult Subjects with Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-SHUTTLE) |
|
5
|
A Phase 3, Multicenter, Double-blind Maintenance study to Assess the Long term Safety, Tolerability, and Efficacy of Rocatinlimab (AMG 451) in Adult and Adolescent Subjects with Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASCEND) |
|
6
|
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Adult Subjects with Generalized Pustular Psoriasis
|
|
7
|
A Phase 3, Long-Term Extension Study to Evaluate the Safety and Efficacy of Imsidolimab (ANB019) in the Treatment of Adult Subjects with Generalized Pustular Psoriasis
|
|
8
|
Global, multicenter, randomized, double-blind, double dummy, parallel-group, Phase 3b study to assess the efficacy, safety and tolerability of remibrutinib 25 mg b.i.d. in comparison to placebo with omalizumab 300 mg every 4 weeks as active control over 52 weeks in adult patients with CSU inadequantely controlled by second-generation H1-AH
|
Last Update: 05/11/2024